Evogene (EVGN) Q4 2024 Earnings
EVGN·Reported March 6, 2025·Before market open
Evogene reported Q4 2024 revenue of $1.6M, missed analyst consensus of $5.0M by $3.4M. Diluted EPS came in at $0.06, beat the $-0.72 consensus by $0.78.
Revenue
$1.6Mmissed by $3.4M
Consensus: $5.0MDiluted EPS
$0.06beat by $0.78
Consensus: $-0.72
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about Evogene's Q4 2024 earnings report.
Evogene (EVGN) reported Q4 2024 earnings on March 6, 2025 before market open.
Evogene reported revenue of $1.6M and diluted EPS of $0.06 for Q4 2024.
Revenue missed the consensus estimate of $5.0M by $3.4M. EPS beat the consensus estimate of $-0.72 by $0.78.